Eli Lilly agrees to buy weight-loss drugmaker Versanis for nearly $2 billion
July 14 (UPI) -- Eli Lilly announced Friday a $1.93 billion cash deal to buy Versanis, a private clinical-stage biopharmaceutical company focused on weight-loss drugs.…
July 14 (UPI) -- Eli Lilly announced Friday a $1.93 billion cash deal to buy Versanis, a private clinical-stage biopharmaceutical company focused on weight-loss drugs.…